Join to View Full Profile
1900 Sullivan AveuneLower LevelDaly City, CA 94015
Phone+1 650-991-5800
Fax+1 650-991-6385
Dr. Mollick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2001 - 2005
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1994 - 1996
Baylor College of MedicineClass of 1994
Certifications & Licensure
CA State Medical License 2001 - 2022
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- 3 citationsStimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.Holbrook E Kohrt, Roch Houot, Kipp Weiskopf, Matthew J Goldstein, Ferenc Scheeren
The Journal of Clinical Investigation. 2019-06-03 - 192 citationsA Systemic Complete Response of Metastatic Melanoma to Local Radiation and ImmunotherapySusan M. Hiniker, Daniel S. Chen, Sunil Reddy, Daniel T. Chang, Jennifer Jones
Translational Oncology. 2012-12-01 - 29 citationsUsing the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1Pearline Zhaoying Teo, Paul J. Utz, Joseph A. Mollick
Cancer Immunology, Immunotherapy. 2012-06-13
Grant Support
- Using The Allergic Immune System To Target CancerNational Cancer Institute2006–2009
- Muc1-Like Proteins In Cancer ImmunotherapyNational Cancer Institute2005
- Activity Of Breast Cancer Associated AntigenNational Cancer Institute2000–2003
- Activity Of Breast Cancer Associated AntigenNational Cancer Institute1998–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
